Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2026)
Bionano Genomics recorded quarterly Return on Capital Employed of 68.32% in Q1 2026, down 9.39% quarter-over-quarter from 62.45% in Q4 2025, and down 6664.0% year-over-year from 1.04% in Q1 2025.
Bionano Genomics' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 68.32% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 6664.0% year-over-year to 68.32%; the TTM figure through Mar 2026 stood at 68.32% (down 6664.0% YoY), while the FY2025 annual figure was 63.89%, down 4215.0% from the prior year.
- Return on Capital Employed came in at 68.32% for Q1 2026 at Bionano Genomics, down from 62.45% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 80.14% in Q3 2025 to a low of 219.36% in Q4 2023.
- A 5-year average of 70.02% and a median of 53.34% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 17227 bps in 2023 and soared 23528 bps in 2025, its largest moves.
- Bionano Genomics' Return on Capital Employed stood at 47.08% in 2022, then slumped by 366 bps to 219.36% in 2023, then jumped by 76 bps to 52.64% in 2024, then slipped by 19 bps to 62.45% in 2025, then fell by 9 bps to 68.32% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 68.32%, 62.45%, and 80.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn | -68.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.32% |
| Dec 31, 2025 | -62.45% |
| Sep 30, 2025 | 80.14% |
| Jun 30, 2025 | 15.76% |
| Mar 31, 2025 | -1.68% |
| Dec 31, 2024 | -52.64% |
| Sep 30, 2024 | -155.14% |
| Jun 30, 2024 | -174.93% |
| Mar 31, 2024 | -163.30% |
| Dec 31, 2023 | -219.36% |
| Sep 30, 2023 | -122.19% |
| Jun 30, 2023 | -59.11% |
| Mar 31, 2023 | -53.34% |
| Dec 31, 2022 | -47.08% |
| Sep 30, 2022 | -42.53% |
| Jun 30, 2022 | -36.32% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -22.25% |
| Sep 30, 2021 | -17.46% |
| Jun 30, 2021 | -13.60% |
| Mar 31, 2021 | -18.54% |
| Dec 31, 2020 | -91.83% |
| Sep 30, 2020 | -363.36% |
| Jun 30, 2020 | -824.22% |
| Mar 31, 2020 | -2,007.72% |
| Dec 31, 2019 | 1,559.26% |
| Sep 30, 2019 | -167.97% |
| Jun 30, 2019 | -126.49% |
| Mar 31, 2019 | -99.12% |
| Dec 31, 2018 | -87.95% |